575 related articles for article (PubMed ID: 20085516)
1. Prognostic factors in desmoid-type fibromatosis: a clinicopathological and immunohistochemical analysis of 46 cases.
Huang PW; Tzen CY
Pathology; 2010 Feb; 42(2):147-50. PubMed ID: 20085516
[TBL] [Abstract][Full Text] [Related]
2. [Clinicopathologic and genetic studies of desmoid-type fibromatosis].
Yang JL; Wang J; Zhou XY; Li XQ; Hou YY; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2006 Mar; 35(3):145-50. PubMed ID: 16630502
[TBL] [Abstract][Full Text] [Related]
3. Expression of beta-catenin and p53 are prognostic factors in deep aggressive fibromatosis.
Gebert C; Hardes J; Kersting C; August C; Supper H; Winkelmann W; Buerger H; Gosheger G
Histopathology; 2007 Mar; 50(4):491-7. PubMed ID: 17448025
[TBL] [Abstract][Full Text] [Related]
4. Analysis of APC, alpha-, beta-catenins, and N-cadherin protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Wroński JW; Kopczyński J; Kulig A; Sidor M; Stalińska L; Dziki A; Sygut J
Pathol Res Pract; 2009; 205(5):311-24. PubMed ID: 19124205
[TBL] [Abstract][Full Text] [Related]
5. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool.
Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM
Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184
[TBL] [Abstract][Full Text] [Related]
6. [Desmoid tumors in patients with familial adenomatous polyposis (FAP). Clinical and therapeutic observations from the Heidelberg polyposis register].
Kadmon M; Möslein G; Buhr HJ; Herfarth C
Chirurg; 1995 Oct; 66(10):997-1005. PubMed ID: 8529453
[TBL] [Abstract][Full Text] [Related]
7. Analysis of TGF-beta protein expression in aggressive fibromatosis (desmoid tumor).
Ferenc T; Stalińska L; Turant M; Sygut J; Tosik D; Dziki A; Kulig A
Pol J Pathol; 2006; 57(2):77-81. PubMed ID: 17019969
[TBL] [Abstract][Full Text] [Related]
8. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
[TBL] [Abstract][Full Text] [Related]
9. Surgical treatment for local control of extremity and trunk desmoid tumors.
Shido Y; Nishida Y; Nakashima H; Katagiri H; Sugiura H; Yamada Y; Ishiguro N
Arch Orthop Trauma Surg; 2009 Jul; 129(7):929-33. PubMed ID: 18810472
[TBL] [Abstract][Full Text] [Related]
10. Analysis of APC/beta-catenin genes mutations and Wnt signalling pathway in desmoid-type fibromatosis.
Jilong Y; Jian W; Xiaoyan Z; Xiaoqiu L; Xiongzeng Z
Pathology; 2007 Jun; 39(3):319-25. PubMed ID: 17558858
[TBL] [Abstract][Full Text] [Related]
11. Gardner fibroma: a clinicopathologic and immunohistochemical analysis of 45 patients with 57 fibromas.
Coffin CM; Hornick JL; Zhou H; Fletcher CD
Am J Surg Pathol; 2007 Mar; 31(3):410-6. PubMed ID: 17325483
[TBL] [Abstract][Full Text] [Related]
12. Deep fibromatosis (desmoid tumor): cytopathologic characteristics, clinicoradiologic features, and immunohistochemical findings on fine-needle aspiration.
Owens CL; Sharma R; Ali SZ
Cancer; 2007 Jun; 111(3):166-72. PubMed ID: 17477374
[TBL] [Abstract][Full Text] [Related]
13. Multimodality management of desmoid tumors: how important is a negative surgical margin?
Melis M; Zager JS; Sondak VK
J Surg Oncol; 2008 Dec; 98(8):594-602. PubMed ID: 19072851
[TBL] [Abstract][Full Text] [Related]
14. Prognostic factors for extra-abdominal and abdominal wall desmoids: a 20-year experience at a single institution.
Huang K; Fu H; Shi YQ; Zhou Y; Du CY
J Surg Oncol; 2009 Dec; 100(7):563-9. PubMed ID: 19722232
[TBL] [Abstract][Full Text] [Related]
15. Desmoid tumor: analysis of prognostic factors and outcomes in a surgical series.
Mullen JT; Delaney TF; Kobayashi WK; Szymonifka J; Yeap BY; Chen YL; Rosenberg AE; Harmon DC; Choy E; Yoon SS; Raskin KA; Petur Nielsen G; Hornicek FJ
Ann Surg Oncol; 2012 Dec; 19(13):4028-35. PubMed ID: 22965569
[TBL] [Abstract][Full Text] [Related]
16. The role of APC and beta-catenin in the aetiology of aggressive fibromatosis (desmoid tumors).
Lips DJ; Barker N; Clevers H; Hennipman A
Eur J Surg Oncol; 2009 Jan; 35(1):3-10. PubMed ID: 18722078
[TBL] [Abstract][Full Text] [Related]
17. Prognostic factors for second recurrence after surgical resection of recurrent desmoid-type fibromatosis.
Cates JM
Pathol Oncol Res; 2015 Sep; 21(4):1085-90. PubMed ID: 25916970
[TBL] [Abstract][Full Text] [Related]
18. Surgical resection margins in desmoid-type fibromatosis: a critical reassessment.
Cates JM; Stricker TP
Am J Surg Pathol; 2014 Dec; 38(12):1707-14. PubMed ID: 25392923
[TBL] [Abstract][Full Text] [Related]
19. Ki-67 expression and residual tumour (R) classification are associated with disease-free survival in desmoid tumour patients.
Brueckl WM; Preuss JM; Wein A; Jung A; Brabletz T; Pflüger R; Wiest GH; Wolfl C; Kirchner T; Hahn EG; Hohenberger W; Günther K
Anticancer Res; 2001; 21(5):3615-20. PubMed ID: 11848532
[TBL] [Abstract][Full Text] [Related]
20. IFN-{beta} signaling positively regulates tumorigenesis in aggressive fibromatosis, potentially by modulating mesenchymal progenitors.
Tjandra SS; Hsu C; Goh YI; Gurung A; Poon R; Nadesan P; Alman BA
Cancer Res; 2007 Aug; 67(15):7124-31. PubMed ID: 17671179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
